Abstract
The Latin American Market for Generic Drugs
Rapid growth, high unmet clinical needs and increasing regulation are changing
the face of Latin American pharmaceuticals. What are the opportunities and
challenges for companies and investors wanting to develop or enter this
growing market? This major strategic study compares 7 key markets.
Answering important questions about the future of generic drugs in Latin America
- What effect is the move to better GMP and bioequivalence having on the
market now, and what impact might it have on domestic companies in the future?
- Patents and intellectual property have risen to the top of the industry's
agenda, but is there political will to enforce compliance?
- What role are ambitious Indian generic manufacturers taking in the region
and what is their on going impact likely to be?
| 
View Cart
